Research ArticleOMERACT 11
Updating the OMERACT Filter: Implications of Filter 2.0 to Select Outcome Instruments Through Assessment of “Truth”: Content, Face, and Construct Validity
Peter Tugwell, Maarten Boers, Maria-Antonietta D’Agostino, Dorcas Beaton, Annelies Boonen, Clifton O. Bingham III, Ernest Choy, Philip G. Conaghan, Maxime Dougados, Catia Duarte, Daniel E. Furst, Francis Guillemin, Laure Gossec, Turid Heiberg, Désirée M. van der Heijde, Sarah Hewlett, John R. Kirwan, Tore K. Kvien, Robert B. Landewé, Philip J. Mease, Mikkel Østergaard, Lee Simon, Jasvinder A. Singh, Vibeke Strand and George Wells
The Journal of Rheumatology May 2014, 41 (5) 1000-1004; DOI: https://doi.org/10.3899/jrheum.131310
Peter Tugwell
From the Department of Medicine, University of Ottawa, Ottawa, Ontario,
Canada; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam,
The Netherlands; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris,
France; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario,
Canada; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University,
The Netherlands; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland,
USA; Section of Rheumatology, Cardiff University School of Medicine, Cardiff,
UK; Division of Musculoskeletal Disease, University of Leeds, and the UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit,
UK; Rheumatology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra,
Portugal; Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles, Los Angeles, California,
USA; Université de Lorraine, EA 4360 APEMAC, Nancy; Université Pierre et Marie Curie (UPMC) - Paris 6, GRC-UMPC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris,
France; Oslo University Hospital and Lovisenberg Diaconal University College, Oslo,
Norway; Department of Rheumatology, Leiden University Medical Center, Leiden,
The Netherlands; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol,
UK; Department of Rheumatology, Diakonhjemmet Hospital, Oslo,
Norway; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center Heerlen, Heerlen,
The Netherlands; Seattle Rheumatology Associates, Chief, Swedish Medical Center Rheumatology Research Division, Clinical Professor, University of Washington School of Medicine, Seattle, Washington; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania,
USA; Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen,
Denmark; SDG LLC, Cambridge, Massachusetts; Division of Immunology/Rheumatology, University of Alabama at Birmingham and Birmingham VA Medical Center, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California,
USA; Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario,
Canada.
Maarten Boers
Maria-Antonietta D’Agostino
Dorcas Beaton
Annelies Boonen
Clifton O. Bingham III
Ernest Choy
Philip G. Conaghan
Maxime Dougados
Catia Duarte
Daniel E. Furst
Francis Guillemin
Laure Gossec
Turid Heiberg
Désirée M. van der Heijde
Sarah Hewlett
John R. Kirwan
Tore K. Kvien
Robert B. Landewé
Philip J. Mease
Mikkel Østergaard
Lee Simon
Jasvinder A. Singh
Vibeke Strand
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 41, Issue 5
1 May 2014
Updating the OMERACT Filter: Implications of Filter 2.0 to Select Outcome Instruments Through Assessment of “Truth”: Content, Face, and Construct Validity
Peter Tugwell, Maarten Boers, Maria-Antonietta D’Agostino, Dorcas Beaton, Annelies Boonen, Clifton O. Bingham, Ernest Choy, Philip G. Conaghan, Maxime Dougados, Catia Duarte, Daniel E. Furst, Francis Guillemin, Laure Gossec, Turid Heiberg, Désirée M. van der Heijde, Sarah Hewlett, John R. Kirwan, Tore K. Kvien, Robert B. Landewé, Philip J. Mease, Mikkel Østergaard, Lee Simon, Jasvinder A. Singh, Vibeke Strand, George Wells
The Journal of Rheumatology May 2014, 41 (5) 1000-1004; DOI: 10.3899/jrheum.131310
Updating the OMERACT Filter: Implications of Filter 2.0 to Select Outcome Instruments Through Assessment of “Truth”: Content, Face, and Construct Validity
Peter Tugwell, Maarten Boers, Maria-Antonietta D’Agostino, Dorcas Beaton, Annelies Boonen, Clifton O. Bingham, Ernest Choy, Philip G. Conaghan, Maxime Dougados, Catia Duarte, Daniel E. Furst, Francis Guillemin, Laure Gossec, Turid Heiberg, Désirée M. van der Heijde, Sarah Hewlett, John R. Kirwan, Tore K. Kvien, Robert B. Landewé, Philip J. Mease, Mikkel Østergaard, Lee Simon, Jasvinder A. Singh, Vibeke Strand, George Wells
The Journal of Rheumatology May 2014, 41 (5) 1000-1004; DOI: 10.3899/jrheum.131310